Program

※Excerpt only international sessions

The following programs listed below are to take place physically on June 18-20 at PACIFICO YOKOHAMA, North. All the programs will be available for live-streaming. On-demand videos are also available for the participants at post-meeting website from July 21 to Aug 4.

Timetable (PDF)

Invited Lecture: Novel risk factors for progression of CKD

Date: 11:00-11:50, June 18 (Fri)
Venue: Room 1 (G1, North 1F, PACIFICO YOKOHAMA)

Chair: Kunihiro Yamagata
(Department of Nephrology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba)

Speaker: Csaba P Kovesdy
(University of Tennessee Health Science Center)

Special Session＜Can Japanese evidence change the world?＞1
“RCTs on MBD from Japan”

Date: 16:00-18:00, June 18 (Fri)
Venue: Room 3 (G303+G304, North 3F, PACIFICO YOKOHAMA)

Chairs: Tadao Akizawa
(Showa University); Eiichiro Kanda
(Medical Science, Kawasaki Medical School)

1. Moving from pyramid of evidence to yin and yang of evidence: Both RCTs and observational studies guide practice

Noriaki Kurita
(Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University)

2. The J-DAVID Trial and cardio-protective effects of vitamin D receptor activation

Tetsuo Shoji
(Department of Vascular Medicine, Osaka City University Graduate School of Medicine)

3. Effect of Treating Hyperphosphatemia with Lanthanum Carbonate (LC) vs Calcium Carbonate on Cardiovascular Events in Hemodialysis Patients

Hiroaki Ogata
(Division of Nephrology, Department of Internal Medicine, Showa University Northern Yokohama Hospital)

4. EPISODE study

Yoshitaka Isaka
(Department of Nephrology, Osaka University Graduate School of Medicine)

5. Clinical research in nephrology: the good, the bad, and ugly

Yoshitsugu Obi
(Division of Nephrology, University of Tennessee Health Science Center)

Special Session＜Can Japanese evidence change the world?＞2
“Clinical Practice Patterns of ESRD Patients”

Date: 13:30-16:00, June 20 (Sun)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Masafumi Fukagawa
(Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine); Kosaku Nitta
(Tokyo Women's Medical University)

1. What makes Japanese dialysis therapy distinctive in the world - messages from the DOPPS data

Norio Hanafusa
(Department of Blood Purification, Tokyo Women's Medical University)

2. Management of CKD-MBD: Are Japanese different from other populations?

Hirotaka Komaba
(Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine)

3. The management of renal anemia: in the world of iron deficiency and in the world of iron overload

Takayuki Hamano
(Department of Nephrology, Nagoya City University Graduate School of Medical Sciences)

4. Is predilution on-line hemodiafiltration the best dialysis modality? Then, for what?

Ikuto Masakane
(Department of Nephrology, Yabuki Hospital)

5. Selection and management of vascular access: Is fistula the best?

Motonobu Nakamura
(Division of Nephrology and Endocrinology, The University of Tokyo)

6. Decision making for initiation and withholding renal replacement therapy among Japanese end stage kidney disease patients: Special consideration of culture and super aging society

Yasuhiro Komatsu
(Department of Healthcare Quality and Safety, Gunma University Graduate School of Medicine)

Symposium 1 “Science of Uremic Toxins”

Date: 9:00-11:00, June 18 (Fri)
Venue: Room 3 (G303+G304, North 3F, PACIFICO YOKOHAMA)

Chairs: Reiko Inagi
(Division of CKD Pathophysiology, The University of Tokyo, Graduate School of Medicine); Suguru Yamamoto
(Niigata University Medical and Dental Hospital)

1. Gut microbiota, diet, and chronic kidney disease

Wendy S. Garrett
(Harvard T.H. Chan School of Public Health)

2. TBD

Takaaki Abe
(Department of Clinical Biology and Hormonal Regulation, Tohoku University School of medicine)

3. Sarcopenia and uremic toxins

Hiroshi Watanabe
(Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University)

4. Uremic toxins- related bone metabolic disorder in chronic kidney disease

Yoshiko Iwasaki
(Department of Health Sciences, Oita University of Nursing and Health Sciences)

5. Interactions between the nervous system and the kidney

Shinji Tanaka
(University of Virginia, Division of Nephrology and the Center for Immunity, Inflammation and Regenerative Medicine)

International comparison in epidemiology of chronic kidney disease

*Onsite and Live streaming only

Date: 9:00-10:30, June 20 (Sun)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Harold I. Feldman
(Center for Clinical Epidemiology and Biostatistics, and University of Pennsylvania / Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania); Naohiko Fujii
(Department of Nephrology, Hyogo Prefectural Nishinomiya Hospital)

1. International collaboration of chronic kidney disease cohort studies: iNET-CKD network

Harold I. Feldman
(Center for Clinical Epidemiology and Biostatistics, and University of Pennsylvania / Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania)

2. Association between Serum Indices of Iron Metabolism and Cardiovascular Morbidity in Patients with Predialysis Chronic Kidney Disease

Takeshi Hasegawa
(Showa University Research Administration Center (SURAC), Showa University, Division of Nephrology, Department of Medicine, School of Medicine, Showa University)

3. Etiological information for risk stratification of chronic kidney disease based on past kidney biopsy

Takayuki Hamano
(Department of Nephrology Nagoya City University Graduate School of Medical Sciences)

4. Socioeconomic status and prognosis of patients with predialysis chronic kidney disease in Japan

Naohiko Fujii
(Department of Nephrology, Hyogo Prefectural Nishinomiya Hospital)

5. CVD prevalence and β-blocker prescribing in CKD: A comparison between Japan and the United States

Takahiro Imaizumi
(Department of Advanced Medicine, Nagoya University Hospital / Department of Nephrology, Nagoya University Graduate School of Medicine)

Asian session・APSN CME Joint symposium “Asian nephrology after COVID-19”

Date: 9:00-11:00, June 18 (Fri)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Xue-Qing Yu
(APSN CME Committee Chair); Masaomi Nangaku
(President of APSN)

1. JSN post COVID-19: JSN's approach to the COVID-19 pandemic

Naoki Kashihara
(President of JSN)

2. APSN post COVID-19: Looking into the Asia Pacific region of post COVID-19 era

Masaomi Nangaku
(President of APSN)

3. KSN post COVID-19: The Strategy of Korean Society of Nephrology to Overcome COVID19

Chul Woo Yang
(President of KSN)

4. TSN post COVID-19

Shang-Jyh Hwang
(President of TSN)

JSN/ASN Joint Symposium

Date: 9:00-11:00, June 19 (Sat)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Susan E. Quaggin
(Northwestern University); Naoki Kashihara
(Department of Nephrology/Hypertension, Kawasaki Medical School)

1. TBD

Susan E. Quaggin
(Northwestern University)

2. TBD

3. TBD

Naoki Kashihara
(Department of Nephrology/Hypertension, Kawasaki Medical School)

4. Fate and consequence of podocyte injury

Taiji Matsusaka
(Department of Basic Medicine, Tokai University School of Medicine)

JSN/ERA-EDTA Joint Symposium

Date: 15:00-17:00, June 19 (Sat)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Mårten Segelmark
(Lund University); Motoko Yanagita
(Department of Nephrology, Graduate School of Medicine, Kyoto University)

1. Reconsideration of dissimilarity in European and Japanese IgA nephropathy

Yusuke Suzuki
(Department of Nephrology, Juntendo University Graduate School of Medicine)

2. Removal of autoantibodies in rapidly progressive glomerulonephritis-with plasma exchance, with exzymatic degradation or not all?

Mårten Segelmark
(Lund University)

3. Clinical outcomes of lupus nephritis in Japan: results from a nationwide registry

Keiju Hiromura
(Department of Nephrology and Rheumatology, Gunma University)

4. Rituximab treatment in MCD and FSGS: what are the evidences and mechanisms of action

Andreas Kronbicher
(Department of Medicine, University of Cambridge)

5. RNA targeted therapies in kidney disease

Maria Vanessa Pérez-Gómez
(Fundación Jiménez Díaz University Hospital)

6. Role of macrophages in the protective effect of the kidney through the autonomic nervous system

Tsuyoshi Inoue
(Department of Physiology of Visceral Function and Body Fluid, Graduate School of Biomedical Sciences, Nagasaki University)

JSN/KDIGO Joint Symposium

Date: 16:00-18:00, June 18(Fri)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Yusuke Tsukamoto
(Department of Nephrology, IMS Itabashi Chuo Medical Center); Kunitoshi Iseki
(Nakamura Clinic, Clinical Research Support Center)

1. AKD as a new concept

Paul E Stevens
(East Kent Hospitals University NHS Foundation Trust)

2. Participation in "KDIGO in Genetics" working group as a researcher

Kandai Nozu
(Kobe University Graduate School of Medicine)

3. Participating in KDIGO Conference on ADPKD Guidance as a Patient

Kaori Yamane Winston
(PKDFCJ)

JSN/KDIGO session on DKD

Date: 10:30-12:00, June 20 (Sun)
Venue: Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)

Chairs: Takashi Wada
(Department of Nephrology and Laboratory Medicine, Kanazawa University); Shin-ichi Araki
(Department of Medicine, Division of Diabetology, Endocrinology, and Nephrology, Shiga University of Medical Science)

1. KDIGO Guideline on Diabetes Management in Chronic Kidney Disease

Adrian Liew
(Mount Elizabeth Novena Hospital)

2. Early Identification and Intervention in CKD

Magdalena Madero Rovalo
(National Institute of Cardiology Ignacio Chavez)

3. Japanese clinicopathological evidence on DKD

Kengo Furuichi
(Kanazawa Medical University Department of Nephrology)

Oshima Award Lecture

Date: 13:30-14:00, June 18 (Fri)
Venue: Room 1 (G3+G4, North 1F, PACIFICO YOKOHAMA)

Chair: Yoshitaka Isaka
(Department of Nephrology, Osaka University Graduate School of Medicine)

1. Generation of interspecies chimeric nephrons from renal progenitor cells using developmental organ niche

Shuichiro Yamanaka
(Department of Internal Medicine, Division of Nephrology and Hypertension, Jikei University School of Medicine)

2. DNA damage repair and altered epigenome in the kidney: as useful markers and therapeutic targets

Kaori Hayashi
(Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Keio University School of Medicine)

CSA (Clinical Scientist Award) Lecture

Date: 14:00-14:30, June 18 (Fri)
Venue: Room 1 (G3+G4, North 1F, PACIFICO YOKOHAMA)

Chair: Keiko Uchida
(Tokyo Women's Medical University)

1. The Emerging Role of Magnesium in CKD

Yusuke Sakaguchi
(Department of Inter-Organ Communication Research in Kidney Diseases, Osaka University)

2. A tight link between CKD-MBD and malnutrition-inflammation complex syndrome (MICS) in patients receiving hemodialysis

Shunsuke Yamada
(Department of Nephrology, Hypertension, and Strokology, Kyushu University)

YIA (Young Investigator Award) Session

Date: 14:00-14:45, June 20 (Sun)
Venue: Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)

Chairs: Akira Nishiyama
(Dept. of Pharmacology, Faculty of Medicine, Kagawa University); Shinji Kume
(Shiga University of Medical Science)

1. Effects of canagliflozin on anemia in patients with type 2 diabetes and chronic kidney disease

Megumi Oshima
(Department of Nephrology and Laboratory Medicine, Kanazawa University,)

2. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury

Yuhei Kirita
(Department of Nephrology, Kyoto Prefectural University of Medicine)

3. Profibrotic circulating proteins and risk of early progressive renal decline in Type 2 Diabetes patients with and without albuminuria

Katsuhito Ihara
(Tokyo Medical and Dental University / Joslin Diabetes center Harvard medical school)

Best Abstract Session – Basic 1 (Regular submission)

Date: 9:00-10:00, June 20 (Sun)
Venue: Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)

Chairs: Miki Nagase
(Kyorin University); Katsuhiko Asanuma
(Chiba University)

1.【BA-01】Long-lasting glucose-independent renoprotective effects by pulse therapy with nicotinamide mononucleotide in early stage of diabetic nephropathy

Itaru Yasuda
(Department of Internal Medicine, School of Medicine, Keio University)

2.【BA-02】T-cell repertoire in tonsil of IgA nephropathy

Kazunori Satokata
(Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences)

3.【BA-03】Intravital ATP imaging reveals a pathophysiological mechanism for podocyte injury after ischemic reperfusion injury

Masahiro Takahashi
(Department of Nephrology, Graduate School of Medicine, Kyoto University)

4.【BA-04】The difference of the disease mechanism for focal segmental glomerulosclerosis due to the variance of the MAFB gene mutation position

Toshiaki Usui
(Department of Nephrology, Faculty of Medicine, University of Tsukuba)

5.【BA-05】Treatment with antisense-oligonucleotide or splicing regulating proteins for X-linked Alport syndrome cases with deep intronic variants

Tomoko Horinouchi
(Department of Pediatrics, Kobe University Graduate School of Medicine)

Best Abstract Session – Basic 2 (Regular submission)

Date: 9:00-11:00, June 20 (Sun)
Venue: Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)

Chairs: Ryuihi Nishinakamura
(Kumamoto University); Takashi Yokoo
(The Jikei University School of Medicine)

1.【BA-06】Alox15 knock-out mice show improvement of kidney dysfunction and fibrosis in chronic kidney disease by increased PGD2 in the kidney

Naohiro Takahashi
(Department of Nephrology, Tokyo Medical and Dental University)

2.【BA-07】Renal congestion accelerates ischemia-reperfusion acute kidney injury

Takashi Kitani
(Department of Nephrology, Kyoto Prefectural University of Medicine)

3.【BA-08】Single-cell analysis of phosphate-induced kidney injury

Yusuke Katsuma
(Department of Nephrology, Osaka University Graduate School of Medicine)

4.【BA-09】Dietary magnesium insufficiency induces salt-sensitive hypertension in mice associated with reduced kidney COMT activity

Asako Kumagai (Department of Obstetrics and Gynecology, Juntendo University)

5.【BA-10】miRNA expression profiling in age-dependent renal impairment

Katsunori Yanai
(Saitama Medical Center, Jichi Medical University)

Best Abstract Session – Clinical (Regular submission)

Date: 11:00-12:00, June 20 (Sun)
Venue: Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)

Chairs: Koichi Asahi
(Iwate Medical University); Jyunichi Hoshino
(Toranomon Hospital)

1.【BA-11】The distribution of eGFR by age in healthy community-based population

Araumi Akira
(Department of Nephrology and Rheumatology, Yamagata University)

2.【BA-12】Association between albuminuria and diabetic nephropathy lesions in autopsy cases with diabetes mellitus : the Hisayama Study

Takaya Sasaki
(Department of Epidemiology and Public Health, Kyushu University)

3.【BA-13】Sodium-glucose cotransporter 2 inhibitors (SGLT2i) use and anemia in diabetic CKD

Miho Murashima
(Nagoya City University)

4.【BA-14】Burden of Kidney Disease on Discrepancy between Reasons for Admission and Death: A Nationwide Cohort Study of Japanese Adults

Shintaro Mandai
(Nephrology, Tokyo Medical and Dental University)

5.【BA-15】Clinical effects of aldosterone receptor antagonists in dialysis patients: a systematic review

Takeshi Hasegawa
(Showa University Research Administration Center)

Late Breaking Abstracts

Date: 14:45-16:00, June 20 (Sun)
Venue: Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)

Chairs: Shinichi Uchida
(Department of Nephrology, Tokyo Medical and Dental University); Daijo Inaguma
(Department of Internal Medicine, Fujita Health University Bantane Hospital)

1.【LBA-1】Renal NG2-expressing cells have macrophage-like activity and facilitate renal recovery after ischemic injury

Wararat Kittikulsuth
(Department of Pharmacology, Kagawa University)

2.【LBA-2】False-negative diagnosis of high anion gap in patients with end-stage kidney disease

Masato Ikeda
(Division of Nephrology and Hypertension, The Jikei University School of Medicine Kashiwa Hospital)

3.【LBA-3】Low Phosphorus Meals Decrease Blood CKD-MBD Indicators and Inflammatory Cytokine in Maintenance Hemodialysis Patients

Barbara Ying-Jung Chen
(School of Nutrition and Health Science, Taipei Medical University)

4.【LBA-4】Polypharmacy, CKD, and incident fracture: a Japanese hospital-based cohort study from the Project in Sado for Total Health (PROST)

Minako Wakasugi
(Department of Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences)

5.【LBA-5】Temporal Change of Serum Anti-SARS-CoV-2 IgG Antibody Levels in Hemodialysis Patients with COVID-19

Hiroko Beppu
(Department of Nephrology, Tokyo Metropolitan Health and Medical Treatment Corporation Ohkubo Hospital)

5.【LBA-6】Clinical course of kidney injury in hospitalized patients with mild or moderate COVID-19

Lisa Uchida
(Department of Nephrology, JCHO Tokyo Shinjuku Medical Center)

CKD-English (Regular submission)

Date: 11:00-12:00, June 20 (Sun)
Venue: Room 5 (G316+G317, North 3F, PACIFICO YOKOHAMA)

Chairs: Yusuke Tsukamoto
(Itabashi Chuo Medical Center); Yoshinari Yasuda
(Nagoya University)

1.【O-162】Compliance and adherence to drug treatment on patients with Chronic Kidney Disease (CKD) in high prevalence areas of North Central Province, Sri Lanka

N. A. Sanjeewani
(Department of Pharmacy, General Sir John Kotelawala Defence University)

2.【O-163】Association of eGFR index category and annual slope with adverse clinical outcomes in Japan

Keizo Kanasaki
(Internal Medicine 1, Faculty of Medicine, Shimane University)

3.【O-164】Effect of Daratumumab (DARA) + Bortezomib, Cyclophosphamide, Dexamethasone (VCd) on Renal Organ Response and Health-Related Quality of Life (HRQoL) in Patients With Systemic Light Chain (AL) Amyloidosis: ANDROMEDA Japanese Subgroup

Andrea Havasi
(Boston University School of Medicine)

4.【O-165】Mineralocorticoid Receptor Antagonist and Hard Renal Outcome in a Real-World CKD Population: A Marginal Structural Model Analysis

Tatsufumi Oka
(Department of Nephrology, Osaka University)

5.【O-166】Circulating Proteins as Prognostic Biomarkers of End-stage Kidney Disease in Diabetes

Katsuhito Ihara
(Joslin Diabetes Center, Harvard Medical School)